Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion

Doeschka A. Ferro, Henk Mutsaerts, Saima Hilal, Hugo J. Kuijf, Esben Thade Petersen, Jan Petr, Susanne J. van Veluw, Narayanaswamy Venketasubramanian, Tan Boon Yeow, Geert Jan Biessels, Christopher ChenJournal of Cerebral Blood Flow & Metabolism 2019 · DOI

TL;DR

This study reveals that the presence of tiny brain lesions (cortical microinfarcts or CMIs) in memory clinic patients is linked to a general decrease in blood flow throughout the brain's anterior circulation. Importantly, the blood flow directly around these microinfarcts was not specifically reduced, suggesting CMIs are more a consequence of broader perfusion issues than a cause of localized deficits.

What Problem Does This Paper Address?

Cerebral cortical microinfarcts (CMIs) are small, often silent, ischemic lesions in the brain's cortex. They are frequently found in patients experiencing cognitive decline and dementia. Researchers have long suspected that reduced blood flow (hypoperfusion) might contribute to the development of CMIs, especially since they often appear in "watershed" areas of the brain that are at the fringes of major blood supply territories. However, it remained unclear whether CMIs were primarily a cause of localized hypoperfusion or a consequence of a more widespread problem with blood flow regulation. This paper aims to disentangle this relationship by investigating if CMIs are associated with reduced cerebral perfusion, both globally and specifically in the immediate vicinity of the lesions.

Methods

The researchers utilized arterial spin labeling (ASL), a non-invasive MRI technique, to measure cerebral blood flow (CBF) and a novel parameter called spatial coefficient of variation (CoV). ASL works by magnetically labeling blood in the neck arteries and then tracking how this labeled blood perfuses the brain tissue. CBF directly quantifies the amount of blood reaching the brain. Spatial CoV, on the other hand, is a proxy for arterial transit time (ATT), which reflects how long it takes for blood to travel through the brain's vasculature. A higher CoV suggests slower or more variable blood flow.

They also employed voxel-based analysis to examine CBF across the entire brain cortex and created region-of-interest (ROI) analyses to specifically measure CBF in a 2-cm sphere around identified CMIs and in a corresponding area on the opposite side of the brain.

Datasets

The study analyzed data from 181 memory clinic patients. These patients were recruited from the National University Hospital and St. Luke's Hospital in Singapore. The data included structural MRI scans, ASL perfusion scans, and neuropsychological test results.

Key Insights and Ideas

  • CMIs as a marker of global hypoperfusion: The most striking finding is that CMIs are not just isolated events but rather indicators of a more pervasive issue with blood flow to the brain. This suggests that addressing factors contributing to global hypoperfusion might be crucial for preventing or managing CMIs.
  • No localized hypoperfusion around CMIs: The fact that blood flow directly surrounding CMIs was not significantly different from control regions is a key insight. This challenges the idea that CMIs themselves actively cause a reduction in blood flow in their immediate vicinity.
  • Spatial CoV as a valuable tool: The use of spatial CoV as a measure related to arterial transit time highlights its utility in assessing perfusion in conditions where standard CBF measurements might be less reliable, such as in patients with cerebrovascular disease.
  • Shared underlying etiologies: The findings support the idea that CMIs and reduced perfusion might share common underlying causes, such as small vessel disease (SVD), hypertension, or other vascular risk factors.

Key Results

  • Patients with CMIs showed a 12% lower cerebral blood flow (CBF) in the anterior circulation compared to those without CMIs (p = .016).
  • After accounting for age and sex, this difference remained significant for CBF (p = .038).
  • Patients with CMIs also exhibited a 22% higher spatial CoV, indicating altered arterial transit time (p = .006). This association also persisted after adjusting for age and sex (p = .039).
  • Crucially, the CBF in a 2-cm region around the CMIs was not significantly different from the CBF in the contralateral hemisphere (p = .97).
  • A voxel-based analysis revealed a relatively homogeneous pattern of hypoperfusion across the cortex in patients with CMIs, rather than a localized deficit.

Limitations and Future Work

The authors acknowledge several limitations:

  • Limited sensitivity of 3-T MRI: The 3-T MRI used can only detect a fraction of CMIs compared to higher field strength MRI or neuropathological examination. The clinical significance of these smaller, undetected CMIs remains unknown.
  • Large ROIs: Due to ASL's signal-to-noise ratio limitations, relatively large 2-cm ROIs were used around CMIs. This might have diluted any potential localized perfusion differences.
  • Exclusion of severely affected patients: A significant proportion of patients (23%) with poor ASL scan quality, often due to severe cognitive impairment, had to be excluded. This might limit the generalizability of the findings to the most severely affected individuals.
  • Watershed atlas limitations: The use of a group-averaged watershed atlas might not perfectly capture individual variations in watershed regions.

Future research directions suggested include:

  • Exploring CMIs and perfusion using ultra-high field MRI to detect smaller lesions.
  • Investigating mechanisms that link CMIs to global hypoperfusion, including causal relationships and shared etiologies.
  • Focusing on clinical populations known for compromised cerebral perfusion (e.g., heart failure patients) to further understand these links.
  • Utilizing novel measures of small vessel function and blood-brain barrier integrity to gain deeper insights into SVD.
  • Exploring cerebral perfusion as a potential therapeutic target for vascular cognitive impairment.

Summary updated

Abstract

Cerebral cortical microinfarcts (CMIs) are small ischemic lesions associated with cognitive impairment and dementia. CMIs are frequently observed in cortical watershed areas suggesting that hypoperfusion contributes to their development. We investigated if presence of CMIs was related to a decrease in cerebral perfusion, globally or specifically in cortex surrounding CMIs. In 181 memory clinic patients (mean age 72 ± 9 years, 51% male), CMI presence was rated on 3-T magnetic resonance imaging (MRI). Cerebral perfusion was assessed from cortical gray matter of the anterior circulation using pseudo-continuous arterial spin labeling parameters <i>cerebral blood flow</i> (CBF) (perfusion in mL blood/100 g tissue/min) and <i>spatial coefficient of variation</i> (CoV) (reflecting arterial transit time (ATT)). Patients with CMIs had a 12% lower CBF (beta = -.20) and 22% higher spatial CoV (beta = .20) (both <i>p</i> < .05) without a specific regional pattern on voxel-based CBF analysis. CBF in a 2 cm region-of-interest around the CMIs did not differ from CBF in a reference zone in the contralateral hemisphere. These findings show that CMIs in memory clinic patients are primarily related to global reductions in cerebral perfusion, thus shedding new light on the etiology of vascular brain injury in dementia.
BibTeX
@article{ferro2019cortical,
  author = {Doeschka A. Ferro and Henk Mutsaerts and Saima Hilal and Hugo J. Kuijf and Esben Thade Petersen and Jan Petr and Susanne J. van Veluw and Narayanaswamy Venketasubramanian and Tan Boon Yeow and Geert Jan Biessels and Christopher Chen},
  title = {{Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion}},
  journal = {Journal of Cerebral Blood Flow \& Metabolism},
  year = {2019},
  doi = {10.1177/0271678x19877403},
}
Figure